Catalyst Wire Dossier Catalyst Wire Dossier

N-Acetyl-GED-0507-34-LEVO Gel 5%

· PPM Services S.A.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for N-Acetyl-GED-0507-34-LEVO Gel 5%, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1) [Phase 3]

See pricing